News Conference News TCT 2017 3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike Yael L. Maxwell October 31, 2017
News Daily News Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke Yael L. Maxwell September 18, 2017
News Daily News Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease Yael L. Maxwell September 15, 2017
News Conference News ESC 2017 Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death Yael L. Maxwell September 01, 2017
News Daily News After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients Yael L. Maxwell August 24, 2017
News Daily News Closing the Mitral Gap: Early Pascal Experience Shows Promise for High-Risk MR Patients Yael L. Maxwell August 22, 2017
News Daily News Stent Fracture, Reintervention Lessened With Prestenting Before Melody Pulmonary Valve Implantation Yael L. Maxwell August 16, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Conference News SCCT 2017 Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions Yael L. Maxwell July 08, 2017
News Conference News EuroPCR 2017 The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone Yael L. Maxwell May 17, 2017
News Daily News Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction Yael L. Maxwell April 18, 2017
News Daily News Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care Yael L. Maxwell April 14, 2017
News Daily News SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation Yael L. Maxwell April 04, 2017
News Daily News MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages Yael L. Maxwell March 27, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News TAVR: Miracle for Some, but No Improvements in Quality of Life for Others Yael L. Maxwell December 22, 2016